Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Chimeric locked nucleic acid-deoxynucleoside phosphorothioate-linked oligonucleotide directed against microRNA-451

EU orphan designation number: EU/3/11/940   
Active ingredient: Chimeric locked nucleic acid-deoxynucleoside phosphorothioate-linked oligonucleotide directed against microRNA-451
Indication: Treatment of polycythaemia vera
Sponsor: Miragen Therapeutics Europe Ltd
90 High Holborn, London WC1V 6XX, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/01/2012 Centralised Orphan - Designation EMA/OD/107/11 (2012)126 of 11/01/2012